SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced that new data further validating the clinical utility of the company’s Decipher Prostate genomic test will be ...
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent studies in basic, translational and clinical cancer research from MD Anderson experts.
Siemens Healthineers and Varian present AI solutions on the treatment planning pathway at ASTRO 2021
This year’s ASTRO annual meeting saw Siemens Healthineers and Varian focus on artificial intelligence (AI). In this short video, filmed at ASTRO 2021, Lisa-Marie Petzold from Siemens Healthineers ...
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced ...
AUSTIN, Texas, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results